Cart
sales@molnova.com
Dihydrotanshinone I
CAS No. 87205-99-0
Dihydrotanshinone I( DHTS | Dihydrotanshinone I )
Catalog No. M16341 CAS No. 87205-99-0
Dihydrotanshinone I (DHTS) was previously reported to exhibit the most potent anti-Y activity among several tanshinones in colon Y cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 180 | In Stock |
|
| 50MG | 253 | In Stock |
|
| 100MG | 405 | In Stock |
|
| 200MG | 588 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydrotanshinone I
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydrotanshinone I (DHTS) was previously reported to exhibit the most potent anti-Y activity among several tanshinones in colon Y cells.
-
DescriptionDihydrotanshinone I (DHTS) was previously reported to exhibit the most potent anti-Y activity among several tanshinones in colon Y cells. Its cytotoxic action was reactive oxygen species (ROS) dependent but p53 independent.
-
In Vitro——
-
In Vivo——
-
SynonymsDHTS | Dihydrotanshinone I
-
PathwayImmunology/Inflammation
-
TargetROS
-
RecptorROS
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number87205-99-0
-
Formula Weight278.31
-
Molecular FormulaC18H14O3
-
Purity>98% (HPLC)
-
SolubilitySoluble in Chloroform
-
SMILESCC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3C=CC=C4C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang L, et al.Phytomedicine. 2015 Nov 15;22(12):1079-87.;
molnova catalog
related products
-
2,8-Quinolinediol
2,8-Quinolinediol
-
Cyfluthrin
Cyfluthrin binds to voltage-sensitive sodium channel such as Nav 1.8 sodium channel and modify their gating kinetics, thereby disrupting nerve function of pests.
-
SFI003
SFI003 is a novel SRSF3 inhibitor that exerts anticancer activity against colorectal cancer by modulating the SRSF3 / DHCR24 / ROS axis and driving apoptosis in CRC cells through the SRSF3 / DHCR24 / reactive oxygen species (ROS) axis.
